The current financial score of agilon health inc is 6.33. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 1.49B, representing a year-over-year increase of 7.15%, while its net profit experienced a year-over-year increase of 117.20%.
The current valuation score of agilon health inc is 9.22. Its current P/E ratio is -4.16, which is -91.83% below the recent high of -0.34 and -2934.26% above the recent low of -126.30.
The current earnings forecast score of agilon health inc is 6.75. The average price target is 112.02, with a high of 146.00 and a low of 6.25.
The current price momentum score of agilon health inc is 4.69. Currently, the stock price is trading between the resistance level at 98.03 and the support level at 81.45, making it suitable for range-bound swing trading.
The current institutional shareholding score of agilon health inc is 7.00. The latest institutional shareholding proportion is 87.96%, representing a quarter-over-quarter decrease of 12.61%. The largest institutional shareholder is James Simons, holding a total of 152.21K shares, representing 0.02% of shares outstanding, with 165.56% increase in holdings.
The current risk assessment score of agilon health inc is 3.43. The company's beta value is 2.88. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.